Overview

Oestrogen Treatment for COVID-19 Symptoms

Status:
Not yet recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The aim of this trial is to determine whether oestrogen treatment mitigates disease progression and severity in confirmed COVID19.
Phase:
Phase 2
Details
Lead Sponsor:
Hamad Medical Corporation
Collaborator:
Laboratoires Besins International
Treatments:
Estradiol